Position in GPCR
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$21,468
+$2,188 QoQ
Shares Held
400
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#170
of 191 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WOLFF WIESE MAGANA LLC holds $439,460 across 18 Biotechnology names. GPCR ranks #3 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IBRX |
ImmunityBio, Inc.
|
37,774 | $330,711 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
89 | $44,208 | |
| 3 | GPCR |
Structure Therapeutics Inc.
This page
|
400 | $21,468 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
125 | $9,783 | |
| 5 | OLMA |
Olema Pharmaceuticals, Inc.
|
600 | $7,506 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
24 | $5,874 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
100 | $5,454 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
35 | $4,290 |
All Filings in GPCR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,468 | 400 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $19,280 | 400 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $27,820 | 400 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $8,008 | 286 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $5,931 | 286 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $2,319 | 134 | Shares | Sole | 2025-04-22 | |
| No filing history on record for this holder in this stock. | ||||||